The invention provides a method for measuring binding of a test compound to a G-Protein Coupled Receptor (GPCR). The invention also provides a method for identifying and measuring the effect that an agent has upon modulating the binding of a test compound to a G-Protein Coupled Receptor.

 
Web www.patentalert.com

> MODIFIED HUMAN THYMIC STROMAL LYMPHOPOIETIN

~ 00377